Home » News
News
launched a toolkit to help health systems design, plan and implement programmes that manage incidental pulmonary nodules (IPNs), opening a route to earlier detection of lung cancer outside risk-based screening
We share our reflections from the World Conference on Lung Cancer 2026, from our sessions on policy engagement and financing to the shift now underway from ambition to implementation.
With growing political support and more countries moving from pilots to implementation, the question facing European health systems now is how to build programmes that are high-quality, equitable, scalable and sustainable.
Timely diagnosis and treatment save lives – yet in many health systems, delays remain the norm. In July 2026, the Network hosted a webinar examining this problem and the role timed targets can play in solving it.
At this year’s World Conference on Lung Cancer (WCLC), the Network will host two sessions designed bridge this gap: one focused on the skills needed to influence policy, and the other on the financing and delivery of lung cancer priorities in practice.
Timed targets set time frames for diagnosis, treatment and other aspects of care, and are a practical way to improve outcomes and accountability.
At our free webinar on Monday 13 July, a global panel of clinicians, professors and patient advocates will share their perspectives on how timed targets can support better, more equitable lung cancer care.
The Network joined global health leaders at the 79th World Health Assembly in May to advance a shared priority: translating growing political ambition on lung cancer into measurable, system-wide progress.
A new article in Nature Medicine presents findings from the first five years of the NHS screening programme for lung cancer in England, and the results are striking.
Last month, the Network attended the inaugural Lung Cancer Europe conference in Vienna, which focused on the power of co‑creation in advocacy.
In March, the Network attended the International Early Lung Cancer Action Program 3rd Annual AGILEᴰˣᴿˣ meeting in Gdańsk, Poland.
The Lung Cancer Policy Network has updated its interactive map of lung cancer screening to help users explore screening research and policies easier, faster, and with more insight.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses the following additional cookies:
Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
More information about our <a href="/privacy-policy/" target="_blank" rel="noopener">Data Privacy Policy</a>.